Clinical trial
Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With…
NCT00285584 · NYU Langone Health, Other · Completed
Key facts
| NCT number | NCT00285584 |
|---|---|
| Title | Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With Men (MSM) |
| Official title | Drug Abuse, Depression and Responses to HIV Counseling |
| Lead sponsor | NYU Langone Health, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections, Depression |
| Intervention type | Drug |
| Interventions | Bupropion, Placebo |
| Enrollment | 41 |
| Start date | Sep 1, 2002 |
| Primary completion | Mar 1, 2004 |
| Completion | Sep 1, 2004 |
| First posted | Feb 2, 2006 |
| Last update posted | Dec 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: